These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
90 related articles for article (PubMed ID: 29485395)
1. Human parainfluenza virus type 2 V protein inhibits caspase-1. Ohta K; Matsumoto Y; Nishio M J Gen Virol; 2018 Apr; 99(4):501-511. PubMed ID: 29485395 [TBL] [Abstract][Full Text] [Related]
2. Claudin-1 inhibits human parainfluenza virus type 2 dissemination. Yumine N; Matsumoto Y; Ohta K; Fukasawa M; Nishio M Virology; 2019 May; 531():93-99. PubMed ID: 30856486 [TBL] [Abstract][Full Text] [Related]
3. Identification of amino acids essential for the human parainfluenza type 2 virus V protein to lower the intracellular levels of the STAT2. Kozuka Y; Yamashita Y; Kawano M; Tsurudome M; Ito M; Nishio M; Komada H; Ito Y Virology; 2003 Dec; 317(2):208-19. PubMed ID: 14698661 [TBL] [Abstract][Full Text] [Related]
4. Profilin2 is required for filamentous actin formation induced by human parainfluenza virus type 2. Ohta K; Matsumoto Y; Nishio M Virology; 2019 Jul; 533():108-114. PubMed ID: 31150988 [TBL] [Abstract][Full Text] [Related]
5. Human parainfluenza virus type 2 V protein inhibits and antagonizes tetherin. Ohta K; Goto H; Yumine N; Nishio M J Gen Virol; 2016 Mar; 97(3):561-570. PubMed ID: 26675672 [TBL] [Abstract][Full Text] [Related]
6. Human parainfluenza virus type 2 V protein inhibits genome replication by binding to the L protein: possible role in promoting viral fitness. Nishio M; Ohtsuka J; Tsurudome M; Nosaka T; Kolakofsky D J Virol; 2008 Jul; 82(13):6130-8. PubMed ID: 18417591 [TBL] [Abstract][Full Text] [Related]
7. Common and unique mechanisms of filamentous actin formation by viruses of the genus Orthorubulavirus. Ohta K; Matsumoto Y; Nishio M Arch Virol; 2020 Apr; 165(4):799-807. PubMed ID: 32100137 [TBL] [Abstract][Full Text] [Related]
8. The V protein of human parainfluenza virus 2 antagonizes type I interferon responses by destabilizing signal transducer and activator of transcription 2. Parisien JP; Lau JF; Rodriguez JJ; Sullivan BM; Moscona A; Parks GD; Lamb RA; Horvath CM Virology; 2001 May; 283(2):230-9. PubMed ID: 11336548 [TBL] [Abstract][Full Text] [Related]
9. The conserved carboxyl terminus of human parainfluenza virus type 2 V protein plays an important role in virus growth. Nishio M; Tsurudome M; Ishihara H; Ito M; Ito Y Virology; 2007 May; 362(1):85-98. PubMed ID: 17250865 [TBL] [Abstract][Full Text] [Related]
10. Identification of paramyxovirus V protein residues essential for STAT protein degradation and promotion of virus replication. Nishio M; Tsurudome M; Ito M; Garcin D; Kolakofsky D; Ito Y J Virol; 2005 Jul; 79(13):8591-601. PubMed ID: 15956600 [TBL] [Abstract][Full Text] [Related]
11. Recombinant human parainfluenza virus type 2 with mutations in V that permit cellular interferon signaling are not attenuated in non-human primates. Schaap-Nutt A; D'Angelo C; Amaro-Carambot E; Nolan SM; Davis S; Wise SM; Higgins C; Bradley K; Kim O; Mayor R; Skiadopoulos MH; Collins PL; Murphy BR; Schmidt AC Virology; 2010 Oct; 406(1):65-79. PubMed ID: 20667570 [TBL] [Abstract][Full Text] [Related]
12. Recovery of infectious human parainfluenza type 2 virus from cDNA clones and properties of the defective virus without V-specific cysteine-rich domain. Kawano M; Kaito M; Kozuka Y; Komada H; Noda N; Nanba K; Tsurudome M; Ito M; Nishio M; Ito Y Virology; 2001 May; 284(1):99-112. PubMed ID: 11352671 [TBL] [Abstract][Full Text] [Related]
13. Identification of human parainfluenza virus type 2 (HPIV-2) V protein amino acid residues that reduce binding of V to MDA5 and attenuate HPIV-2 replication in nonhuman primates. Schaap-Nutt A; Higgins C; Amaro-Carambot E; Nolan SM; D'Angelo C; Murphy BR; Collins PL; Schmidt AC J Virol; 2011 Apr; 85(8):4007-19. PubMed ID: 21289116 [TBL] [Abstract][Full Text] [Related]
14. Binding of the V proteins to the nucleocapsid proteins of human parainfluenza type 2 virus. Watanabe N; Kawano M; Tsurudome M; Nishio M; Ito M; Ohgimoto S; Suga S; Komada H; Ito Y Med Microbiol Immunol; 1996 Sep; 185(2):89-94. PubMed ID: 8884740 [TBL] [Abstract][Full Text] [Related]
15. Synthesis of human parainfluenza virus 4 nucleocapsid-like particles in yeast and their use for detection of virus-specific antibodies in human serum. Bulavaitė A; Lasickienė R; Tamošiūnas PL; Simanavičius M; Sasnauskas K; Žvirblienė A Appl Microbiol Biotechnol; 2017 Apr; 101(7):2991-3004. PubMed ID: 28102432 [TBL] [Abstract][Full Text] [Related]
16. The Fusion Protein Specificity of the Parainfluenza Virus Hemagglutinin-Neuraminidase Protein Is Not Solely Defined by the Primary Structure of Its Stalk Domain. Tsurudome M; Ito M; Ohtsuka J; Hara K; Komada H; Nishio M; Nosaka T J Virol; 2015 Dec; 89(24):12374-87. PubMed ID: 26423949 [TBL] [Abstract][Full Text] [Related]
17. Human parainfluenza virus type 2 V protein inhibits interferon production and signaling and is required for replication in non-human primates. Schaap-Nutt A; D'Angelo C; Scull MA; Amaro-Carambot E; Nishio M; Pickles RJ; Collins PL; Murphy BR; Schmidt AC Virology; 2010 Feb; 397(2):285-98. PubMed ID: 19969320 [TBL] [Abstract][Full Text] [Related]
18. Murine Gammaherpesvirus 68 Pathogenesis Is Independent of Caspase-1 and Caspase-11 in Mice and Impairs Interleukin-1β Production upon Extrinsic Stimulation in Culture. Cieniewicz B; Dong Q; Li G; Forrest JC; Mounce BC; Tarakanova VL; van der Velden A; Krug LT J Virol; 2015 Jul; 89(13):6562-74. PubMed ID: 25855746 [TBL] [Abstract][Full Text] [Related]
19. High resistance of human parainfluenza type 2 virus protein-expressing cells to the antiviral and anti-cell proliferative activities of alpha/beta interferons: cysteine-rich V-specific domain is required for high resistance to the interferons. Nishio M; Tsurudome M; Ito M; Kawano M; Komada H; Ito Y J Virol; 2001 Oct; 75(19):9165-76. PubMed ID: 11533180 [TBL] [Abstract][Full Text] [Related]
20. Genetic diversity among human parainfluenza virus type 2 isolated in Croatia between 2011 and 2014. Šantak M; Slović A; Ljubin-Sternak S; Mlinarić Galinović G; Forčić D J Med Virol; 2016 Oct; 88(10):1733-41. PubMed ID: 27004845 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]